Cleared Special

K100050 - R & D SYSTEMS XERET HEMATOLOGY CONTROL

K100050 is an FDA 510(k) clearance for R & D SYSTEMS XERET HEMATOLOGY CONTROL, manufactured by R&D Systems, Inc.. The device is a Class 2 Hematology device with product code JPK cleared through the Special 510(k) pathway after a 21-day FDA review.

Download Printable Device Report (PDF) Official FDA 510(k) Summary (PDF)
Optimized for regulatory review, auditing and printing
Jan 2010
Decision
21d
Days
Class 2
Risk

K100050 is an FDA 510(k) clearance for the R & D SYSTEMS XERET HEMATOLOGY CONTROL. Classified as Mixture, Hematology Quality Control (product code JPK), Class II - Special Controls.

Submitted by R&D Systems, Inc. (Minneapolis, US). The FDA issued a Cleared decision on January 29, 2010 after a review of 21 days - a notably fast clearance cycle.

This device falls under the Hematology FDA review panel, regulated under 21 CFR 864.8625 - the FDA hematology device framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Low regulatory complexity profile. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

FDA 510(k) Submission Details - K100050

510(k) Number K100050 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received January 08, 2010
Decision Date January 29, 2010
Days to Decision 21 days
Submission Type Special
Review Panel Hematology (HE)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
92d faster than avg
Panel avg: 113d · This submission: 21d
Pathway characteristics
Modification to existing cleared device.

JPK Device Classification - Class 2, Special Controls

Product Code JPK Mixture, Hematology Quality Control
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 864.8625
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Hematology devices follow this clearance model.

Regulatory Peers - JPK Mixture, Hematology Quality Control

All 188
Devices cleared under the same product code (JPK) and FDA review panel - the closest regulatory comparables to K100050.
COULTER LIN-X LINEARITY CONTROL, MODEL A81196
K100790 · Beckman Coulter, Inc. · Dec 2010
COULTER 4C-EX 300 CELL CONTROL
K100607 · Beckman Coulter, Inc. · Nov 2010
LIQUICHEK HEMATOLOGY-16 CONTROL LV, MODEL: 295LV
K091303 · Bio-Rad Laboratories · Aug 2010
R&D SYSTEMS TETIC-I PLUS HEMOTOLOGY CONTROL
K091433 · R&D Systems, Inc. · Oct 2009
UA-CELLULAR FOR IQ
K090201 · Streck · Mar 2009
COULTER BODY FLUID CONTROL
K082162 · Beckman Coulter, Inc. · Feb 2009